Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 6
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Combination of Amoxicillin 3000 mg and Probenecid Versus 1500 mg Amoxicillin Monotherapy for Treating Syphilis in Patients With Human Immunodeficiency Virus: An Open-Label, Randomized, Controlled, Non-Inferiority Trial.
Ando N, Mizushima D, Omata K, Nemoto T, Inamura N, Hiramoto S, Takano M, Aoki T, Watanabe K, Uemura H, Shiojiri D, Yanagawa Y, Tanuma J, Teruya K, Kikuchi Y, Gatanaga H, Oka S. Ando N, et al. Among authors: inamura n. Clin Infect Dis. 2023 Sep 11;77(5):779-787. doi: 10.1093/cid/ciad278. Clin Infect Dis. 2023. PMID: 37157863 Clinical Trial.
Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants.
Mizoue T, Yamamoto S, Konishi M, Oshiro Y, Inamura N, Nemoto T, Ozeki M, Horii K, Okudera K, Sugiyama H, Aoyanagi N, Sugiura W, Ohmagari N. Mizoue T, et al. Among authors: inamura n. J Infect. 2022 Nov;85(5):573-607. doi: 10.1016/j.jinf.2022.08.015. Epub 2022 Aug 20. J Infect. 2022. PMID: 35995310 Free PMC article. No abstract available.
Antibody responses and correlates after two and three doses of BNT162b2 COVID-19 vaccine.
Yamamoto S, Tanaka A, Oshiro Y, Inamura N, Mizoue T, Ohmagari N; for SARS-CoV-2 Seroepidemiological Study among NCGM staff. Yamamoto S, et al. Among authors: inamura n. Infection. 2023 Apr;51(2):523-525. doi: 10.1007/s15010-022-01898-5. Epub 2022 Aug 4. Infection. 2023. PMID: 35925506 Free PMC article. No abstract available.
Preinfection Neutralizing Antibodies, Omicron BA.5 Breakthrough Infection, and Long COVID: A Propensity Score-Matched Analysis.
Yamamoto S, Matsuda K, Maeda K, Horii K, Okudera K, Oshiro Y, Inamura N, Nemoto T, Takeuchi JS, Li Y, Konishi M, Tsuchiya K, Gatanaga H, Oka S, Mizoue T, Sugiyama H, Aoyanagi N, Mitsuya H, Sugiura W, Ohmagari N. Yamamoto S, et al. Among authors: inamura n. J Infect Dis. 2023 Dec 20;228(12):1652-1661. doi: 10.1093/infdis/jiad317. J Infect Dis. 2023. PMID: 37756608
15 results